A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2011
11/24/2011	US20110288166 Triptolide c-ring derivatives as anticancer agents and immune modulators
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288157 RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288145 Novel Formulation For L-Tryptophane Comprising Carbidopa/Benserazide
11/24/2011	US20110288140 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers
11/24/2011	US20110288129 Amide derivatives as trpv1 antagonists
11/24/2011	US20110288127 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/24/2011	US20110288123 Formulations for the treatment of acute herpes zoster pain
11/24/2011	US20110288114 Compositions for the treatment of fibrotic diseases or conditions
11/24/2011	US20110288112 Method of Providing Sustained Analgesia With Buprenorphine
11/24/2011	US20110288109 New compounds
11/24/2011	US20110288100 Therapeutic agents useful for treating pain
11/24/2011	US20110288099 Compositions with reduced hepatotoxicity
11/24/2011	US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011	US20110288094 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
11/24/2011	US20110288093 Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives
11/24/2011	US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
11/24/2011	US20110288085 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
11/24/2011	US20110288079 Tannate Compositions, Methods of Making and Methods of Use
11/24/2011	US20110288074 New adenosine receptor ligands and uses thereof
11/24/2011	US20110288071 Substituted pyrimidines for the treatment of diseases such as cancer
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288067 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288066 Phenoxy acetic acid derivatives
11/24/2011	US20110288061 Triterpenoid derivatives, benzenoid derivatives and pharmaceutical compositions containing the same
11/24/2011	US20110288060 apparatus and process for producing crystals
11/24/2011	US20110288058 Methods for Preventing or Reducing Colon Carcinogenesis
11/24/2011	US20110288056 Once daily formulations of tetracyclines
11/24/2011	US20110288054 Compounds for the treatment of inflammatory disorders
11/24/2011	US20110288047 Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations
11/24/2011	US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System
11/24/2011	US20110288035 Pimap39 modulates inflammatory response
11/24/2011	US20110288033 Disulfide Compounds for Phototherapy
11/24/2011	US20110288017 Apo-lipoprotein propeptide
11/24/2011	US20110288011 Peptide therapeutic conjugates and uses thereof
11/24/2011	US20110288006 Peptides and methods for inducing cell death
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
11/24/2011	US20110287103 Sustained-release formulations of topiramate
11/24/2011	US20110287093 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
11/24/2011	US20110287091 Chronotherapeutic pharmaceutical composition
11/24/2011	US20110287088 Modulation of olfml-3 mediated angiogenesis
11/24/2011	US20110287083 Bioabsorbable Composition and Coatings Including Same
11/24/2011	US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof
11/24/2011	US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/24/2011	US20110287059 Honey analysis
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287048 Antigen Specific Tregs and related compositions, methods and systems
11/24/2011	US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
11/24/2011	US20110287032 Novel ctla4-ig immunoadhesins
11/24/2011	US20110287030 Compositions and methods for diagnosing and treating an inflammation
11/24/2011	US20110287028 Methods of Treatment Using Human Anti-IL-23 Antibodies
11/24/2011	US20110287027 Pain treatment
11/24/2011	US20110287023 High Affinity Antibodies Against HMGB1 and Methods of Use Thereof
11/24/2011	US20110287022 Interferon alpha-induced pharmacodynamic markers
11/24/2011	US20110287017 Anti-p-selectin antibodies and methods of their use and identification
11/24/2011	US20110287000 Treatment of autoimmune and inflammatory disease
11/24/2011	US20110286986 Lactoferrin and angiogenin compositions and uses thereof
11/24/2011	US20110286982 Glucagon analogues
11/24/2011	US20110286981 Glucagon analogues
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	US20110286638 Systems and methods for remote work sessions
11/24/2011	CA2799904A1 Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
11/24/2011	CA2799579A1 Chemical compounds, compositions and methods for kinase modulation
11/24/2011	CA2799480A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
11/24/2011	CA2799202A1 Compositions and methods for treatment of autoimmune and other diseases
11/24/2011	CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388258A1 Novel vanilloid receptor ligands and their use for producing medicaments
11/23/2011	EP2387573A1 6-phenyl-lh-imidazo ý4, 5-c¨pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors
11/23/2011	EP2387572A2 Protein kinase c inhibitors and uses thereof
11/23/2011	EP2387565A2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
11/23/2011	EP2387418A1 Pain treatment
11/23/2011	EP2387402A2 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
11/23/2011	EP2222299B1 Use of levocabastine for modulating generation of pro-inflammatory cytokines
11/23/2011	EP1951674B1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
11/23/2011	EP1904048B1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
11/23/2011	EP1716868B1 Anti-inflammatory analgesic for external use
11/23/2011	EP1633758B1 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
11/23/2011	EP1569937B1 C-6 modified indazolylpyrrolotriazines
11/23/2011	EP1531841B1 Probiotics for gut neuromuscular functions
11/23/2011	EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	EP1385527B2 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
11/23/2011	EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins
11/23/2011	CN202043972U Health-care pillow with headrest provided with three layers of medicine cushions
11/23/2011	CN102256965A Pyrimidin-2-ylamino derivatives and their use to treat inflammation
11/23/2011	CN102256964A Compuestos inhibidores de quinasa map p38
11/23/2011	CN102256963A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
11/23/2011	CN102256947A Substituted 4-(1,2,3,4-tetrahydroisochinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
11/23/2011	CN102256942A New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
11/23/2011	CN102256941A New salts
11/23/2011	CN102256621A Pain treatment
11/23/2011	CN102256617A Annexin and its use to treat inflammatory disorders
11/23/2011	CN102250737A Wine with health-care effect
11/23/2011	CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound
11/23/2011	CN102250251A Polyethylene glycol derivative of enkephalin analogue

1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 1272